Abstract
Immunosenescence can reduce the immune system’s ability to destroy cancer cells and effectively respond to pathogens, thereby increasing susceptibility to cancer development and proliferation. Previous studies have shown that T cell senescence might be one of the important features of immunosenescence mechanism, but lack of single cell evidences. This study aimed to investigate the associations between immunosenescence cells and treatment responses of Lung squamous cell cancer (LUSC) patients who received neoadjuvant immunotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.